Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

Good morning, we have news of a big M&A deal this morning. Let’s get into it. Merck said this moring that it will buy Verona ...

Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored ...

The Global Fibromyalgia Treatment Market is expected to reach at a CAGR of 4.2 % during the forecast period 2025-2033. The ...

Here is how Astellas Pharma Inc. (ALPMY) and AtriCure (ATRC) have performed compared to their sector so far this year.

Astellas Pharma Inc., a leading multinational pharmaceutical company, filed the present suit against Astellaz Pharmaceuticals, seeking a permanent injunction to restrain the defendant from infringing ...

Here is how Astellas Pharma Inc. (ALPMY) and AngioDynamics (ANGO) have performed compared to their sector so far this year.

EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ -- Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with ...

Ascendis Pharma UK, a subsidiary of the global biopharmaceutical company with a portfolio of products and product candidates specialising in rare endocrine diseases, has opened a UK office and ...

Pfizer’s 2024 Super Bowl spot reportedly beat out fellow pharma advertiser Astellas’ Veozah ad in terms of their respective engagement boosts following last year’s big game.

A little more than a year after Astellas Pharma won Food and Drug Administration (FDA) approval for geographic atrophy (GA) drug Izervay, it’s kicking off its first direct-to-consumer (DTC) campaign ...